Company Registration No. 04223939 (England and Wales)
Hampton Knight Limited
Annual report and financial statements
for the year ended 30 September 2024
Hampton Knight Limited
Contents
Page
Statement of financial position
1
Notes to the financial statements
2 - 6
Hampton Knight Limited
Statement of financial position
As at 30 September 2024
1
30 September
29 September
2024
2023
Notes
£
£
£
£
Current assets
Trade and other receivables
3
6,358,911
6,358,911
Net current assets
6,358,911
6,358,911
Net assets
6,358,911
6,358,911
Equity
Called up share capital
4
100
100
Retained earnings
6,358,811
6,358,811
Total equity
6,358,911
6,358,911
The directors of the company have elected not to include a copy of the income statement within the financial statements.
For the financial year ended 30 September 2024 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.
The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The financial statements were approved by the board of directors and authorised for issue on 25 June 2025 and are signed on its behalf by:
Alexander Goldsmith
Director
Company registration number 04223939 (England and Wales)
Hampton Knight Limited
Notes to the financial statements
For the year ended 30 September 2024
2
1
Accounting policies
Company information
Hampton Knight Limited is a private company limited by shares incorporated in England and Wales. The registered office is Medigold House, Queensbridge, Northampton, NN4 7BF.
1.1
Reporting period
The comparative amounts presented in these financial statements are in respect of the 18 month period to 29 September 2023. The comparative amounts presented (including in the related notes) are not entirely comparable a a result.
1.2
Accounting convention
The financial statements have been prepared in accordance with Financial Reporting Standard 101 Reduced Disclosure Framework (FRS 101) and in accordance with applicable accounting standards.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
The financial statements have been prepared under the historical cost convention, modified to include certain financial instruments at fair value. The principal accounting policies adopted are set out below.
As permitted by FRS 101, the company has taken advantage of the following disclosure exemptions from the requirements of IFRS:
inclusion of an explicit and unreserved statement of compliance with IFRS;
presentation of a statement of cash flows and related notes;
disclosure of the objectives, policies and processes for managing capital;
disclosure of key management personnel compensation;
disclosure of the categories of financial instrument and the nature and extent of risks arising on these financial instruments;
the effect of financial instruments on the statement of comprehensive income;
comparative period reconciliations for the number of shares outstanding and the carrying amounts of property, plant and equipment, intangible assets, investment property and biological assets;
disclosure of the future impact of new International Financial Reporting Standards in issue but not yet effective at the reporting date;
comparative narrative information;
related party disclosures for transactions with the parent or wholly owned members of the group.
As permitted by FRS 101, the company has taken advantage of the disclosure exemptions available under that standard in relation to share based payments, financial instruments, capital management, presentation of a cash flow statement, presentation of comparative information in respect of certain assets, standards not yet effective, impairment of assets, business combinations, discontinued operations and related party transactions.
Where required, equivalent disclosures are given in the group accounts of Medigold Health Consultancy Limited. The group accounts of Medigold Health Consultancy Limited are available to the public and can be obtained as set out in the controlling party note.
Hampton Knight Limited is a wholly owned subsidiary of Medigold Health Consultancy Limited and the results of Hampton Knight Limited are included in the consolidated financial statements of Medigold Health Consultancy Limited which are available from Medigold House, Queensbridge, Northampton, NN4 7BF.
Hampton Knight Limited
Notes to the financial statements (continued)
For the year ended 30 September 2024
1
Accounting policies (continued)
3
1.3
Going concern
On 29 September 2023, the trade and net assets of the company were hived up to Medigold Health Consultancy Limited, the company's immediate parent. With effect from this date, the company was no longer trading.true
1.4
Revenue
Revenue is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.
Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of
the goods have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be
measured reliably, it is probable that the economic benefits associated with the transaction will flow to
the entity and the costs incurred or to be incurred in respect of the transaction can be measured
reliably.
Revenue from contracts for the provision of services is recognised by reference to the stage of
completion when the stage of completion, costs incurred and costs to complete can be estimated
reliably. Where the outcome cannot be estimated reliably, revenue is recognised only to the extent of
the expenses recognised that it is probable will be recovered.
The nature, timing of satisfaction of performance obligations and significant payment terms of the company's major sources of revenue are as follows:
1.5
Financial assets
Financial assets are recognised in the company's statement of financial position when the company becomes party to the contractual provisions of the instrument. Financial assets are classified into specified categories, depending on the nature and purpose of the financial assets.
At initial recognition, financial assets classified as fair value through profit and loss are measured at fair value and any transaction costs are recognised in profit or loss. Financial assets not classified as fair value through profit and loss are initially measured at fair value plus transaction costs.
Financial assets held at amortised cost
Financial instruments are classified as financial assets measured at amortised cost where the objective is to hold these assets in order to collect contractual cash flows, and the contractual cash flows are solely payments of principal and interest. They arise principally from the provision of goods and services to customers (eg trade receivables). They are initially recognised at fair value plus transaction costs directly attributable to their acquisition or issue, and are subsequently carried at amortised cost using the effective interest rate method, less provision for impairment where necessary.
Impairment of financial assets
Financial assets carried at amortised cost and FVOCI are assessed for indicators of impairment at each reporting end date.
The expected credit losses associated with these assets are estimated on a forward-looking basis. A broad range of information is considered when assessing credit risk and measuring expected credit losses, including past events, current conditions, and reasonable and supportable forecasts that affect the expected collectability of the future cash flows of the instrument.
Hampton Knight Limited
Notes to the financial statements (continued)
For the year ended 30 September 2024
1
Accounting policies (continued)
4
Derecognition of financial assets
Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire, or when it transfers the financial asset and substantially all the risks and rewards of ownership to another entity.
1.6
Equity instruments
Equity instruments issued by the company are recorded at the proceeds received, net of direct issue costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.
1.7
Taxation
The tax expense represents the sum of the tax currently payable and deferred tax.
Current tax
The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the income statement because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.
Deferred tax
Deferred tax is the tax expected to be payable or recoverable on differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit, and is accounted for using the balance sheet liability method. Deferred tax liabilities are generally recognised for all taxable temporary differences and deferred tax assets are recognised to the extent that it is probable that taxable profits will be available against which deductible temporary differences can be utilised. Such assets and liabilities are not recognised if the temporary difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.
The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the income statement, except when it relates to items charged or credited directly to 'other comprehensive income', in which case the deferred tax is also dealt with in 'other comprehensive income'. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.
1.8
Employee benefits
The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of inventories or non-current assets.
The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.
A termination benefit liability is recognised at the earlier of when the entity can no longer withdraw the offer of the termination benefit and when the entity recognises any related restructuring costs.
Hampton Knight Limited
Notes to the financial statements (continued)
For the year ended 30 September 2024
5
2
Employees
The average monthly number of persons (including directors) employed by the company during the year was:
2024
2023
Number
Number
2
2
3
Trade and other receivables
2024
2023
£
£
Amounts owed by fellow group undertakings
6,358,911
6,358,911
Amounts owed by group undertakings are unsecured, interest free and repayable on demand.
4
Share capital
2024
2023
2024
2023
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary of £1 each
100
100
100
100
Each share is entitled to full voting and participating rights.
Hampton Knight Limited
Notes to the financial statements (continued)
For the year ended 30 September 2024
6
5
Contingent liabilities
On 5 July 2022, the company's parent undertaking, Medigold Health Consultancy Limited, completed a refinancing arrangement with HSBC Bank Plc, obtaining a facility of £9,600,000. On the same date, the existing CBILS facility of £4,000,000 was repaid, extinguishing the existing cross-company guarantee.
On 6 March 2023, the terms of the facility with HSBC Bank Plc were revised and the facility extended by £3,000,000. On the same day:
Medigold Health Consultancy Limited issued unsecured loan notes to the value of £9,000.000 to BGF and £1,000,000 to a collective of existing shareholders and associated Goldsmith family members.
The terms of the existing £4,000,000 of loan notes, originally issued to BGF in 2017, were amended and restated to become secured loan notes.
The company is party to the group guarantee and debenture of fixed and floating charges over the assets of the group, provided as security for these facilities.
At the balance sheet date, the balance due in connection with these facilities was £27,624,000.
Subsequent to the year end, Medigold Health Consultancy Limited completed a further refinancing arrangement with HSBC Bank Plc, BGF and a collective of existing shareholders and Goldsmith family members and friends, extending and revising the terms of the existing facilities. The company remains party to the group guarantee and debenture of fixed and floating charges over the assets of the group, provided as security for these facilities.
6
Related party transactions
The company has taken advantage of the exemption permitted by FRS101 whereby it has not disclosed transactions with the ultimate parent company or any wholly owned subsidiary undertaking of the group.
7
Controlling party
The immediate and ultimate parent company of Hampton Knight Limited is Medigold Health Consultancy Limited.
Medigold Health Consultancy Limited is the parent of the smallest and largest group for which consolidated financial statements are drawn up, of which the company is a member. The registered office of Medigold Health Consultancy Limited is Medigold House, Queensbridge, Northampton, NN4 7BF.
The directors do not consider there to be an ultimate controlling party.